Targeting Persistent AKI and Promoting Recovery

Abstract List

20 Sep 2026 07:30 08:15
Room 101C
Chi-yuan HsuUnited States Speaker Targeting Persistent AKI and Promoting RecoveryDoes Mild to Moderate AKI Actually Cause CKD?
Jay KoynerUnited States Speaker Special lecture: 2026 KDIGO AKI Guideline UpdateI will be updating the audience on the major conceptual updates of the 2026 KDIGO AKI Guidelines. I will focus on Chapter 1 and 2, including the evolving definition of AKI/AKD, AKI trajectories, biomarkers, and risk prediction, together with selected key updates from Chapter 4 on nephrotoxin-associated kidney injuryTargeting Persistent AKI and Promoting RecoveryI have been working with my co-moderators to develop a case based presentation looking at the use of biomarkers to predict outcomes in a patient with dialysis requiring AKI. and we will be discussing the intracicies of providing AKI-care to those receiving dialysis and how best to wean patients from dialysis and the long term outpatient managment of these patients
Shang-Han WuTaiwan Presenter
 

This session will discuss post-AKI care, dialysis-dependent acute kidney disease, and strategies to promote kidney recovery after severe AKI.

The case involves an elderly patient with coronary artery disease, diabetes, hypertension, recent NSAID exposure, and rapidly progressive kidney dysfunction due to MPO-ANCA-associated pauci-immune glomerulonephritis. Despite immunosuppressive therapy, plasma exchange, and rituximab induction, the patient remained dialysis-dependent at discharge after a complicated hospital course.

The discussion will focus on kidney recovery assessment, timing of RAS inhibitor initiation or resumption, structured handoff to community dialysis units, individualized dialysis prescription and weaning, and management of dialysis-related electrolyte depletion.